The deal gives clinicians in PathNet's national lab network access to Valar's AI-powered Vesta diagnostic portfolio for non-muscle invasive bladder cancer.

The digital revolution is now more quickly transforming pathology lab workflows, pointing towards accelerating adoption in the coming years.

Geographic Reach: Fulgent will expand its geographic footprint with the addition of CLIA, CAP, and NY State certified laboratories in Georgia (Bako) and Massachusetts (StrataDx).

Frank has been chief of the Department of Laboratory Medicine at the National Institutes of Health Clinical Center since 2018.

Valar Labs, a leader in AI-powered diagnostics for oncology, today announced a strategic partnership with PathNet Lab, one of the nation's foremost pathology laboratories. Through this collaboration, ...

AI tools designed to diagnose cancer from tissue samples are quietly learning more than just disease patterns. New research ...

Morrill County Community Hospital (MCCH) has reached a historic milestone, citing its clinical laboratory as the first at a ...

Learn how digital connectivity and the PathoVerse are improving pathology workflows and accelerating access to expert ...

Immunotherapy Shows Long-Term Benefits in Allergic Rhinitis In patients with local allergic rhinitis, allergen immunotherapy yields sustained reductions in nasal-ocular symptoms, with preventive ...

Lehigh Valley Health Network and HNL Lab Medicine, a regional leader in high-quality, innovative laboratory medicine services, announce the appointment of Dr. Jordan Olson as chair of pathology for ...

Proprietary Laboratory Analyses (PLA) Codes are an addition to the CPT® code set approved by the AMA CPT® Editorial Panel. They are alpha-numeric CPT codes with a corresponding descriptor for labs or ...